EDIT-301 for anemia, sickle cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Apr 2021: Trial registered, NCT04853576
  2. 4 May 2021: Trial started, NCT04853576

The trials

NCT04853576: A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

State
Under way
Phase
Phase 1 and Phase 2
People
45 planned
Started
4 May 2021
Primary completion
Aug 2025
Arms
EDIT-301
Results
None posted
  1. 21 Apr 2021: Trial registered
  2. 4 May 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Gene therapy.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.